Cysteine

Cysteine

SCHEMBL4245391

C=CC(N)=O.N[C@@H](CS)C(=O)O

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 2/20 0.70
SLC7A11 Q9UPY5 1/20 0.70
TSHR P16473 2/20 0.48
ALDH1A1 P00352 1/20 0.48
FGFR4 P22455 1/20 0.48
GRIK1 P39086 5/20 0.42
GRIK2 Q13002 5/20 0.42
ENPEP Q07075 6/20 0.40
ALOX15 P16050 1/20 0.40
BLM P54132 1/20 0.40
PMP22 Q01453 1/20 0.40
KMT2A Q03164 1/20 0.40
GRM1 Q13255 2/20 0.39
GRM2 Q14416 2/20 0.39
CYP1A2 P05177 2/20 0.38
GLA P06280 1/20 0.38
NFKB1 P19838 1/20 0.38
APEX1 P27695 1/20 0.38
CYP2C19 P33261 1/20 0.38
NOS2 P35228 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cysteine SCHEMBL28283554 1.00 PTGS1 (0.70) PTGS1SLC7A11TSHRALDH1A1FGFR4
Cysteine SCHEMBL1276081 1.00 PTGS1 (0.70) PTGS1SLC7A11TSHRALDH1A1FGFR4
Cysteine SCHEMBL26690254 0.89 PTGS1 (0.55) PTGS1SLC7A11TSHRALDH1A1FGFR4
Cysteine SCHEMBL4023819 0.89 PTGS1 (0.73) PTGS1SLC7A11GRIK1GRIK2ENPEP
Cysteine SCHEMBL4023815 0.89 PTGS1 (0.73) PTGS1SLC7A11GRIK1GRIK2ENPEP
Cysteine SCHEMBL28192928 0.84 PTGS1 (0.73) PTGS1SLC7A11GRIK1GRIK2ENPEP
Cysteine SCHEMBL25292211 0.84 PTGS1 (0.89) PTGS1SLC7A11TSHRGRIK1GRIK2
Cysteine SCHEMBL1819440 0.84 PTGS1 (0.89) PTGS1SLC7A11TSHRGRIK1GRIK2
Cysteine SCHEMBL11344868 0.84 PTGS1 (0.89) PTGS1SLC7A11TSHRGRIK1GRIK2
Cysteine SCHEMBL1819437 0.84 PTGS1 (0.89) PTGS1SLC7A11TSHRGRIK1GRIK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109730110-A L-cysteine or L-cysteine hydrochloride are preparing the application in active carbonyls inhibitor 暨南大学 2019-05-10 CN disclosed
CN-109730111-A The application of L-cysteine or L-cysteine hydrochloride in the chemicals that preparation reduces hydroperoxides and carbonyl valence 暨南大学 2019-05-10 CN disclosed
CN-101052307-B Method for reducing acrylamide formation in thermally processed foods FRITO LAY NORTH AMERICA INC 2011-02-23 CN disclosed
CN-101052317-B Method for reducing acrylamide formation in thermally processed foods FRITO LAY NORTH AMERICA INC 2011-02-02 CN disclosed
CN-100594802-C Method for reducing acrylamide formation in thermally processed foods FRITO LAY NORTH AMERICA INC 2010-03-24 CN disclosed
US-20090140136-A1 Method Of Analyzing Protein NEC CORPORATION (JP) 2009-06-04 US disclosed
US-20090022862-A1 Method to limit acrylamide in heated foods CHILDREN'S MEDICAL CENTER CORPORATION (US) 2009-01-22 US disclosed
CN-101098625-A Method for enhancing acrylamide decomposition FRITO LAY NORTH AMERICA INC (US) 2008-01-02 CN disclosed
CN-101052317-A Method for reducing acrylamide formation in thermally processed foods FRITO LAY NORTH AMERICA INC (US) 2007-10-10 CN disclosed
CN-101052307-A Method for reducing acrylamide formation in thermally processed foods FRITO LAY NORTH AMERICA INC (US) 2007-10-10 CN disclosed
CN-1753622-A Method for reducing acrylamide formation in thermally processed foods FRITO LAY NORTH AMERICA INC (US) 2006-03-29 CN disclosed
WO-2006017526-A2 METHOD TO LIMIT ACRYLAMIDE IN HEATED FOODS CHILDREN'S MEDICAL CENTER CORPORATION (US) 2006-02-16 WO disclosed